Archives of Gynecology and Obstetrics

, Volume 284, Issue 2, pp 357–360 | Cite as

HIV testing in pregnancy: are we testing enough?

  • Bernd Peter Kost
  • Andrea Gingelmaier
  • Franz Kainer
  • Klaus Friese
  • Ioannis Mylonas
General Gynecology

Abstract

Objective

The crucial first step in the prevention of mother-to-child transmission of HIV is awareness of pregnant women of their HIV status. The aim of this study was to define the percentage of patients who received HIV tests between 2001 and 2007 in a German city hospital.

Materials and methods

In this retrospective cohort analysis at a University hospital in a German urban area, 12,873 deliveries were retrospectively analysed to determine whether an HIV test had been performed during prenatal counselling.

Results

The number of HIV tests performed increased significantly between 2001 and 2007 from 59.6 to 76.7%. On average, 69.9% of the analysed deliveries were tested for HIV.

Conclusions

Although awareness of the importance of HIV screening in newborns has increased in recent years, the numbers are still unsatisfactory. Therefore, further education is necessary to prevent HIV infection in early pregnancy and avoid HIV mother-to-child transmission.

Keywords

HIV Testing Recommendation Pregnancy 

Notes

Acknowledgments

The authors would like to thank Mr. M. Feistle and Dr. Irene Alba-Alejandre for their assistance with the analysis.

Conflict of interest

None of the authors has financial, personal, political, intellectual or religious interests in publishing this article.

References

  1. 1.
    Likatavicius G, Klavs I, Devaux I, Alix J, Nardone A (2008) An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000–6: implications for a European public health strategy. Sex Transm Infect 84(6):499–505. doi: 10.1136/sti.2008.031419 PubMedCrossRefGoogle Scholar
  2. 2.
    Robert-Koch-Institut (RKI) (2007) HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten. Halbjahresbericht II. Epidemiologisches Bulletin II/2007Google Scholar
  3. 3.
    Reshi P, Lone IM (2010) Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet 281(5):781–792. doi: 10.1007/s00404-009-1334-3 PubMedCrossRefGoogle Scholar
  4. 4.
    UNAIDS (WHO) (2007) AIDS epidemic update. UNAIDS, GenevaGoogle Scholar
  5. 5.
    Chibber R, Khurranna A (2005) Birth outcomes in perinatally HIV-infected adolescents and young adults in Manipur, India: a new frontier. Arch Gynecol Obstet 271(2):127–131. doi: 10.1007/s00404-003-0564-z PubMedCrossRefGoogle Scholar
  6. 6.
    Olagbuji BN, Ezeanochie MC, Ande AB, Oboro VO (2010) Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch Gynecol Obstet 281(6):991–994. doi: 10.1007/s00404-009-1186-x PubMedCrossRefGoogle Scholar
  7. 7.
    Parisaei M, Hemelaar J, Govind A (2010) HIV in pregnancy: a case of Pneumocystis (carinii) jiroveci pneumonia. Arch Gynecol Obstet 281:1–3. doi: 10.1007/s00404-009-1104-2 PubMedCrossRefGoogle Scholar
  8. 8.
    Ezechi OC, Gab-Okafor C, Onwujekwe DI, Adu RA, Amadi E, Herbertson E (2009) Intimate partner violence and correlates in pregnant HIV positive Nigerians. Arch Gynecol Obstet 280(5):745–752. doi: 10.1007/s00404-009-0956-9 PubMedCrossRefGoogle Scholar
  9. 9.
    Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, Schmied B, Brockmeyer N (2006) German-Austrian recommendations for HIV-therapy in pregnancy, in HIV-exposed newborn—update 2005. Eur J Med Res 11(9):359–376PubMedGoogle Scholar
  10. 10.
    Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM, Swiss HIVCS, Swiss M, Child HIVCS (2008) Antiretroviral treatment during pregnancy. AIDS 22(17):2323–2330. doi: 10.1097/QAD.0b013e3283189bf1 PubMedCrossRefGoogle Scholar
  11. 11.
    American Academy of Pediatrics Committee on Pediatric AIDS (2008) HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 122(5):1127–1134. doi: 10.1542/peds.2008-2175 CrossRefGoogle Scholar
  12. 12.
    Alba-Alejandre I, Kainer F, Friese K, Mylonas I (2009) HbS-Antigen-Nachweis in der Schwangerschaft. Geburtshilfe Und Frauenheilkunde 69:537–540CrossRefGoogle Scholar
  13. 13.
    Weissenbacher TM, Kupka MS, Kainer F, Friese K, Mylonas I (2010) Screening for Chlamydia trachomatis in pregnancy—a retrospective analysis in a German urban area. Arch Gynecol Obstet. doi: 10.1007/s00404-010-1537-7 Google Scholar
  14. 14.
    Robert-Koch-Institut (RKI) (2005) HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten. Halbjahresbericht. Epidemiologisches Bulletin II/2005Google Scholar
  15. 15.
    Gazzard B, Clumeck N, d’Arminio Monforte A, Lundgren JD (2008) Indicator disease-guided testing for HIV—the next step for Europe? HIV Med 9(Suppl 2):34–40. doi: 10.1111/j.1468-1293.2008.00592.x PubMedCrossRefGoogle Scholar
  16. 16.
    Burke RC, Sepkowitz KA, Bernstein KT, Karpati AM, Myers JE, Tsoi BW, Begier EM (2007) Why don’t physicians test for HIV? A review of the US literature. AIDS 21(12):1617–1624. doi: 10.1097/QAD.0b013e32823f91ff PubMedCrossRefGoogle Scholar
  17. 17.
    Rozenbaum MH, Verweel G, Folkerts DK, Dronkers F, van den Hoek JA, Hartwig NG, de Groot R, Postma MJ (2008) Cost-effectiveness estimates for antenatal HIV testing in the Netherlands. Int J STD AIDS 19(10):668–675. doi: 10.1258/ijsa.2008.008077 PubMedCrossRefGoogle Scholar
  18. 18.
    Lee PM, Wong KH (2007) Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong. Hong Kong Med J 13(3):199–207PubMedGoogle Scholar
  19. 19.
    Graves N, Walker DG, McDonald AM, Kaldor JM, Ziegler JB (2004) Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia. J Infect Dis 190(1):166–174. doi: 10.1086/421247JID31756 PubMedCrossRefGoogle Scholar
  20. 20.
    Bramley D, Graves N, Walker D (2003) The cost effectiveness of universal antenatal screening for HIV in New Zealand. AIDS 17(5):741–748. doi: 10.1097/01.aids.0000050810.06065.36 PubMedCrossRefGoogle Scholar
  21. 21.
    Podhurst LS, Storm DS, Dolgonos S (2009) Women’s opinions about routine HIV testing during pregnancy: implications for the opt-out approach. AIDS Patient Care STDS 23(5):331–337. doi: 10.1089/apc.2008.0186 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Bernd Peter Kost
    • 1
  • Andrea Gingelmaier
    • 1
  • Franz Kainer
    • 1
  • Klaus Friese
    • 1
  • Ioannis Mylonas
    • 1
  1. 1.Division of Infectious Diseases in Obstetrics and Gynaecology, Department of Gynaecology and ObstetricsLudwig-Maximilians-University MunichMunichGermany

Personalised recommendations